Results 131 to 140 of about 1,341,364 (309)

The use of human adipose-derived stem cells in the treatment of physiological and pathological vulvar dystrophies [PDF]

open access: yes, 2016
“Vulvar dystrophy” is characterized by chronic alterations of vulvar trophism, occurring in both physiological (menopause) and pathological (lichen sclerosus, vulvar graft-versus-host disease) conditions.
CARELLA, SARA   +4 more
core   +4 more sources

Vulvar Carcinoma: Diagnosis, Staging, and Treatment

open access: yes, 2019
Vulvar cancer accounts for only 5% of all gynecologic cancers with an incidence rate of 2.4 per 100, 000 women. The most common histological type of vulvar cancer is vulvar squamous cell carcinoma (VSCC). There are two different types of VSCC with their own associated premalignant lesions.
Joanne A. de Hullu   +3 more
openaire   +3 more sources

Topical imiquimod and in situ vulvar melanoma: A promising therapy?

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 170, Issue 2, Page 608-613, August 2025.
Abstract Objectives Vulvar melanoma is a rare type of cancer that affects mainly postmenopausal women. There are no established protocols for the treatment of vulvar melanoma. From data extrapolated from the literature on cutaneous melanoma, surgical excision remains the best option for the resectable disease.
Francesca Pepe   +7 more
wiley   +1 more source

Vulvar Metastasis in Renal Cell Carcinoma: A Case Report Highlighting the Aggressive Nature of Clear Cell Renal Cell Carcinoma

open access: yesCurrent Oncology
Vulvar cancer is one of the rarest gynecological malignancies. The development of this condition can be associated with either dysplasia linked to human papillomavirus (HPV), primarily affecting younger women, or vulvar dermatoses such as lichen ...
Andreea Boiangiu   +10 more
doaj   +1 more source

Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities. [PDF]

open access: yes, 2019
BackgroundThe phosphatidylinositol 3-kinase (PI3K) pathway is frequently altered in cancer. This report describes the landscape of PI3K alterations in solid tumors as well as co-alterations serving as potential resistance/attenuation mechanisms ...
Albacker, Lee   +6 more
core   +1 more source

Involvement of KEAP1/NRF2 pathway in non‐BRAF mutated squamous cell carcinoma of the thyroid

open access: yesThe Journal of Pathology, Volume 266, Issue 4-5, Page 481-494, August 2025.
Abstract Squamous cell carcinoma (SCC) of the thyroid is a rare tumor that is classified as an anaplastic thyroid cancer (ATC) due to its similar unresponsiveness to chemoradiotherapy and an outstandingly poor prognosis. Due to its rarity, current knowledge about this tumor is mostly based on single‐case reports.
Elin Schoultz   +13 more
wiley   +1 more source

Carcinoma "in situ"de vulva. [PDF]

open access: yes, 1983
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Departamento de Tocoginecologia, Curso de Medicina, Florianópolis ...
Gentil, Almir Adir
core  

Long‐term quality of life, vulvar symptoms, and sexual functioning: A cross‐sectional study of Norwegian vulvar cancer survivors

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 8, Page 1505-1516, August 2025.
A considerable proportion of vulvar cancer survivors experienced persistent functional impairments, even more than 5 years posttreatment. Additionally, they reported more vulvar symptoms and sexual dysfunction compared to women from a normative population sample.
Christin Julia Meltzer‐Gunnes   +4 more
wiley   +1 more source

Carcinoma vulvar

open access: yesRevista Electrónica Dr. Zoilo E. Marinello Vidaurreta, 2015
El carcinoma de la vulva tiene una incidencia de aproximadamente un 3-5% dentro de todas las enfermedades ginecológicas malignas. El 90% de los tumores malignos de la vulva está constituido por carcinoma epidermoide, el resto son adenocarcinomas ...
Yamit Peñas Zayas   +2 more
doaj  

Home - About - Disclaimer - Privacy